Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

The interactions of a selective protein kinase C beta inhibitor with the human cytochromes P450.

Ring BJ, Gillespie JS, Binkley SN, Campanale KM, Wrighton SA.

Drug Metab Dispos. 2002 Sep;30(9):957-61.

PMID:
12167559
2.

Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine.

Ring BJ, Eckstein JA, Gillespie JS, Binkley SN, VandenBranden M, Wrighton SA.

J Pharmacol Exp Ther. 2001 Jun;297(3):1044-50.

PMID:
11356927
3.

Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities.

Dantzig AH, Shepard RL, Law KL, Tabas L, Pratt S, Gillespie JS, Binkley SN, Kuhfeld MT, Starling JJ, Wrighton SA.

J Pharmacol Exp Ther. 1999 Aug;290(2):854-62.

PMID:
10411602
4.

Autoactivation and activation of the cytochrome P450s.

Ekins S, Ring BJ, Binkley SN, Hall SD, Wrighton SA.

Int J Clin Pharmacol Ther. 1998 Dec;36(12):642-51.

PMID:
9877001
5.

Alterations of the catalytic activities of drug-metabolizing enzymes in cultures of human liver slices.

VandenBranden M, Wrighton SA, Ekins S, Gillespie JS, Binkley SN, Ring BJ, Gadberry MG, Mullins DC, Strom SC, Jensen CB.

Drug Metab Dispos. 1998 Nov;26(11):1063-8.

PMID:
9806947
6.

In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A.

Ring BJ, Binkley SN, Vandenbranden M, Wrighton SA.

Br J Clin Pharmacol. 1996 Mar;41(3):181-6.

7.

Interaction of human liver cytochromes P450 in vitro with LY307640, a gastric proton pump inhibitor.

VandenBranden M, Ring BJ, Binkley SN, Wrighton SA.

Pharmacogenetics. 1996 Feb;6(1):81-91.

PMID:
8845864
8.

Effect of fluoxetine, norfluoxetine, sertraline and desmethyl sertraline on human CYP3A catalyzed 1'-hydroxy midazolam formation in vitro.

Ring BJ, Binkley SN, Roskos L, Wrighton SA.

J Pharmacol Exp Ther. 1995 Dec;275(3):1131-5.

PMID:
8531073
9.

Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.

Sharer JE, Shipley LA, Vandenbranden MR, Binkley SN, Wrighton SA.

Drug Metab Dispos. 1995 Nov;23(11):1231-41.

PMID:
8591724

Supplemental Content

Loading ...
Support Center